Work

Biomarkers of platelet activation and cardiovascular risk in the DAPT trial

Year: 2020

Type: article

Source: Journal of Thrombosis and Thrombolysis

DOI: 10.1007/s11239-020-02221-5

Authors: David D. Berg, Robert W. Yeh, Laura Mauri, David A. Morrow, Dean J. Kereiakes, Donald E. Cutlip, Qi Gao, Petr Jarolim, Alan D. Michelson, Andrew L. Frelinger, Abby L. Cange, Marc S. Sabatine, Michelle L. O’Donoghue

Institutions: Brigham and Women's Hospital, Harvard University, Thrombolysis in Myocardial Infarction Study Group, Beth Israel Deaconess Medical Center, Medtronic (United States), Christ Hospital, Baim Institute for Clinical Research, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: G2643230970, G9000111148, Training Grant in Cardiovascular Research

OpenAlex ID: W3042563002

FWCI: 1.083

Cites: 19

Cited by: 14

Related to: 10